Session » Abstracts: Systemic Sclerosis & Related Disorders – Clinical I
- 1:00PM-2:30PM
-
Abstract Number: 1693
Change in Forced Vital Capacity at Week 12 or 24 Has Prognostic Value for Outcome at Week 52 in Patients with Autoimmune Disease-Related Interstitial Lung Diseases
- 1:00PM-2:30PM
-
Abstract Number: 1690
FAPI-PET/CT as a Predictor of Accelerated Lung Function Deterioration in Systemic Sclerosis Related Interstitial Lung Disease (ILD): Preliminary-interim Analysis from a Confirmatory Risk Factor Study
- 1:00PM-2:30PM
-
Abstract Number: 1694
One-Year Survival Following Single versus Double Lung Transplantation in Adults with Systemic Autoimmune Rheumatic Disease-related Interstitial Lung Disease: A Nationwide Cohort Study
- 1:00PM-2:30PM
-
Abstract Number: 1689
Pulmonary Function Test Reference Equations May Drive Inequitable Classification of Restrictive Lung Disease Severity in Systemic Sclerosis
- 1:00PM-2:30PM
-
Abstract Number: 1692
Single Cell RNA-seq Identifies Circulating Double-negative-2 B-cell Population Associated with Progressive Scleroderma Interstitial Lung Disease
- 1:00PM-2:30PM
-
Abstract Number: 1691
Treatment Response Biomarkers for Systemic Sclerosis-Associated Interstitial Lung Disease